Researchers racing to develop bird flu vaccines for humans have turned to a cutting-edge technology that enabled the rapid development of lifesaving covid shots.

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.

Nature's Toolbox (NTx), a life sciences company developing next-generation platforms for RNA and protein manufacturing, today announced the founding of its Scientific Advisory Board (SAB) with ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

LncRNAs and circRNAs are key regulators of gene expression, influencing disease mechanisms and offering potential as ...

Cancer continues to be a leading cause of mortality worldwide, highlighting the urgent need to develop more advanced, efficient, and early detection methods.

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

Moderna stock is under pressure, again, as Robert F. Kennedy Jr. reportedly mulls pulling the company's federal funding to ...

I'm asking Prosecutor-General Maros Zilinka to take immediate action regarding the results of an analysis of batches of vaccines used against COVID-19 among the Slovak population, Government Proxy for ...

Genevant Sciences and Arbutus Biopharma announced that it has filed five international lawsuits seeking to enforce patents protecting their LNP technology against Moderna, Inc. and certain affiliates.

Researchers suggest that many metamorphic proteins have an 'underlying temperature dependence.' If confirmed, this would mean that temperature -- and cold temperature in particular -- plays a ...